M.D. Volker Knappertz

Insider Reports History

Location
Cambridge, United Kingdom
Signature
/s/ Volker Knappertz, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by M.D. Volker Knappertz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. EVP, Research and Development Common Stock 319,128 $1,946,681 $6.10 27 Feb 2024 Direct
GW PHARMACEUTICALS PLC Chief Medical Officer Ordinary Shares 0 05 May 2021 Direct
GW PHARMACEUTICALS PLC Chief Medical Officer Share Options 0 05 May 2021 Direct

Insider Reports Filed by M.D. Volker Knappertz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUPH Aurinia Pharmaceuticals Inc. 27 Feb 2024 1 -$30,073 4 EVP, Research and Development 29 Feb 2024, 16:11
AUPH Aurinia Pharmaceuticals Inc. 20 Feb 2024 1 -$137,800 4 EVP, Research and Development 22 Feb 2024, 16:35
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2023 1 $0 4 EVP, Research and Development 06 Mar 2023, 15:28
AUPH Aurinia Pharmaceuticals Inc. 01 Aug 2022 2 $0 4 EVP, Research and Development 01 Aug 2022, 16:13
AUPH Aurinia Pharmaceuticals Inc. 18 Jul 2022 0 $0 3 EVP, Research and Development 19 Jul 2022, 17:34
/report/000089924321018663-knappertz-volker-2021-05-05 GW PHARMACEUTICALS PLC 05 May 2021 12 $0 4 Chief Medical Officer 07 May 2021, 16:15